Founded in 2016, Neuralink operates in neurotechnology / medical devices. Its most recent disclosed valuation is $9B (post-money). No public ticker exists for the company.
2 valuations. The latest, $9B pre-money, was set by the Series E in Jun 2025.
ARK InvestLEADSSequoia CapitalLEAD
Founders FundLEADEElon MuskLEAD
Thrive Capital
Lightspeed Venture PartnersDDFJ Growth
G42HHuman Capital
Qatar Investment AuthorityVValor Equity PartnersARK InvestSequoia CapitalFounders FundNeuralink Corp. is an American neurotechnology company developing implantable brain-computer interfaces. It was founded by Elon Musk and a team of eight scientists and engineers, and it is headquartered in Fremont, California, with products aimed at letting people with paralysis control computers and robotic arms with their thoughts.
On January 29, 2024, Musk announced that Neuralink had successfully implanted a Neuralink device in a human and that the patient was recovering. The implanted device, called “the Link,” uses thin, flexible threads equipped with 1,024 electrodes that record the activity of neurons.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Neuralink.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Neuralink availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Neuralink included.
The routes section explains what is realistically available for a company at this stage.
No. Neuralink is a private company; its shares do not trade on a public exchange.
The last valuation is $9B (post-money, Jun 2025).
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
